Calcium and Heart Failure: How Did We Get Here and Where Are We Going?

Natthaphat Siri-Angkul, Behzad Dadfar, Riya Jaleel, Jazna Naushad, Jaseela Parambathazhath, Angelia A Doye, Lai-Hua Xie, Judith K Gwathmey
Author Information
  1. Natthaphat Siri-Angkul: Department of Cell Biology and Molecular Medicine, Rutgers University-New Jersey Medical School, Newark, NJ 07103, USA.
  2. Behzad Dadfar: Department of General Medicine, School of Medicine, Mazandaran University of Medical Sciences, Sari 1471655836, Iran. ORCID
  3. Riya Jaleel: School of International Education, Zhengzhou University, Zhengzhou 450001, China. ORCID
  4. Jazna Naushad: Weill Cornell Medicine Qatar, Doha P. O. Box 24144, Qatar.
  5. Jaseela Parambathazhath: Process Dynamics Laboratories, Al Khor 679576, Qatar.
  6. Angelia A Doye: Gwathmey Inc., Cambridge, MA 02138, USA.
  7. Lai-Hua Xie: Department of Cell Biology and Molecular Medicine, Rutgers University-New Jersey Medical School, Newark, NJ 07103, USA.
  8. Judith K Gwathmey: Department of Cell Biology and Molecular Medicine, Rutgers University-New Jersey Medical School, Newark, NJ 07103, USA.

Abstract

The occurrence and prevalence of heart failure remain high in the United States as well as globally. One person dies every 30 s from heart disease. Recognizing the importance of heart failure, clinicians and scientists have sought better therapeutic strategies and even cures for end-stage heart failure. This exploration has resulted in many failed clinical trials testing novel classes of pharmaceutical drugs and even gene therapy. As a result, along the way, there have been paradigm shifts toward and away from differing therapeutic approaches. The continued prevalence of death from heart failure, however, clearly demonstrates that the heart is not simply a pump and instead forces us to consider the complexity of simplicity in the pathophysiology of heart failure and reinforces the need to discover new therapeutic approaches.

Keywords

References

  1. N Engl J Med. 1991 Nov 21;325(21):1468-75 [PMID: 1944425]
  2. Circ Res. 2007 Jun 8;100(11):1569-78 [PMID: 17556670]
  3. Am J Physiol. 1987 Dec;253(6 Pt 2):H1365-71 [PMID: 3425738]
  4. Pflugers Arch. 1990 Aug;416(6):742-9 [PMID: 2247345]
  5. Int Rev Cytol. 1991;129:45-73 [PMID: 1917380]
  6. Eur J Heart Fail. 2019 Apr;21(4):425-435 [PMID: 30338885]
  7. J Clin Invest. 1968 Jul;47(7):1615-26 [PMID: 4232137]
  8. J Mol Cell Cardiol. 1998 Oct;30(10):1929-37 [PMID: 9799647]
  9. Basic Res Cardiol. 2018 Jun 15;113(4):29 [PMID: 29905892]
  10. Circulation. 2019 May 14;139(20):2358-2371 [PMID: 31082292]
  11. Circulation. 2020 May 12;141(19):e779-e806 [PMID: 32279539]
  12. J Biol Chem. 2019 Jan 4;294(1):28-37 [PMID: 30413532]
  13. Autophagy. 2016 Aug 2;12(8):1340-54 [PMID: 27245989]
  14. J Cardiovasc Pharmacol. 2018 Apr;71(4):248-255 [PMID: 29389740]
  15. Hum Gene Ther. 2013 Nov;24(11):937-47 [PMID: 24164241]
  16. J Gen Physiol. 1985 Feb;85(2):247-89 [PMID: 2580043]
  17. Biophys J. 2008 Sep 15;95(6):3100-10 [PMID: 18539635]
  18. Am J Ther. 1997 Apr;4(4):149-58 [PMID: 10423605]
  19. J Gen Physiol. 1981 Nov;78(5):457-97 [PMID: 6796647]
  20. Eur J Clin Pharmacol. 2020 Aug;76(8):1161-1168 [PMID: 32440720]
  21. J Physiol. 1975 Aug;249(3):497-517 [PMID: 1177102]
  22. JAMA Cardiol. 2021 Jul 1;6(7):769-770 [PMID: 33851950]
  23. Eur J Cardiol. 1976 May;4 Suppl:13-27 [PMID: 1278211]
  24. Pflugers Arch. 2013 Oct;465(10):1439-49 [PMID: 23686296]
  25. Circ Res. 1987 Jul;61(1):70-6 [PMID: 3608112]
  26. Cold Spring Harb Perspect Biol. 2010 Oct;2(10):a003962 [PMID: 20861159]
  27. J Mol Cell Cardiol. 2011 May;50(5):803-12 [PMID: 21093451]
  28. Pflugers Arch. 2021 Mar;473(3):521-531 [PMID: 33594499]
  29. J Comp Physiol B. 2000 Jun;170(4):295-306 [PMID: 10935520]
  30. J Mol Cell Cardiol. 1985 Nov;17(11):1065-75 [PMID: 3908693]
  31. Am J Physiol. 1990 Sep;259(3 Pt 2):H784-95 [PMID: 2204278]
  32. J Am Coll Cardiol. 2008 Mar 18;51(11):1112-9 [PMID: 18342232]
  33. Am J Physiol. 1994 Aug;267(2 Pt 2):H734-41 [PMID: 8067429]
  34. Circulation. 1996 Oct 15;94(8):1894-901 [PMID: 8873665]
  35. Eur J Pharmacol. 2018 Oct 15;837:1-7 [PMID: 30153442]
  36. Cardiovasc Res. 2011 Nov 1;92(2):226-36 [PMID: 21672930]
  37. J Card Fail. 2020 Jul;26(7):599-609 [PMID: 32147520]
  38. Prog Biophys Mol Biol. 2017 Nov;130(Pt B):254-263 [PMID: 28629808]
  39. J Mol Cell Cardiol. 2015 Dec;89(Pt B):160-7 [PMID: 26475411]
  40. Pflugers Arch. 1987 Aug;409(4-5):448-53 [PMID: 3627961]
  41. Am J Cardiol. 1989 Jan 3;63(2):41A-45A [PMID: 2642629]
  42. Expert Opin Investig Drugs. 2002 Nov;11(11):1529-36 [PMID: 12437500]
  43. Cardiovasc Res. 2021 Apr 21;: [PMID: 33881517]
  44. Circ Res. 2009 Nov 6;105(10):1023-30 [PMID: 19797170]
  45. Mol Cell Biochem. 2003 Mar;245(1-2):77-89 [PMID: 12708747]
  46. Adv Pharmacol. 2017;78:203-301 [PMID: 28212798]
  47. Oxid Med Cell Longev. 2020 May 14;2020:5732956 [PMID: 32509147]
  48. Eur Heart J. 2016 Jul 14;37(27):2129-2200 [PMID: 27206819]
  49. Cardiovasc Res. 2015 Oct 1;108(1):21-30 [PMID: 26272755]
  50. Am J Physiol. 1983 Jul;245(1):C1-14 [PMID: 6346892]
  51. Circulation. 2003 Jul 22;108(3):367-72 [PMID: 12876135]
  52. Am J Physiol Cell Physiol. 2008 Mar;294(3):C833-41 [PMID: 18184877]
  53. J Cardiovasc Pharmacol. 2006;47 Suppl 1:S7-14 [PMID: 16785833]
  54. BMJ. 2019 Feb 13;364:l223 [PMID: 30760447]
  55. Can J Physiol Pharmacol. 1984 Jul;62(7):891-8 [PMID: 6498618]
  56. Cardiovasc Res. 2013 Sep 1;99(4):760-8 [PMID: 23786999]
  57. J Physiol. 1978 Mar;276:233-55 [PMID: 25957]
  58. Circ Res. 1985 Dec;57(6):836-43 [PMID: 2933178]
  59. N Engl J Med. 1996 May 23;334(21):1349-55 [PMID: 8614419]
  60. Front Physiol. 2019 Mar 01;10:159 [PMID: 30881310]
  61. Am J Physiol Heart Circ Physiol. 2020 Jan 1;318(1):H181-H188 [PMID: 31809212]
  62. Circulation. 1971 Apr;43(4):467-79 [PMID: 5103275]
  63. Nature. 1978 Jun 15;273(5663):509-13 [PMID: 307184]
  64. Annu Rev Physiol. 2008;70:23-49 [PMID: 17988210]
  65. Cells. 2020 Jan 10;9(1): [PMID: 31936700]
  66. Circ Res. 2009 Jan 2;104(1):79-86 [PMID: 19038865]
  67. J Mol Cell Cardiol. 2020 Dec;149:73-81 [PMID: 32971072]
  68. Soc Gen Physiol Ser. 1986;40:229-38 [PMID: 3520836]
  69. Cell Physiol Biochem. 2011;27(3-4):299-304 [PMID: 21471719]
  70. Nihon Seirigaku Zasshi. 1972 Feb;34(2):95-6 [PMID: 4402921]
  71. Circulation. 2012 Oct 23;126(17):2051-64 [PMID: 22992321]
  72. Cardiovasc Drugs Ther. 2001 Nov;15(6):479-86 [PMID: 11916356]
  73. Symp Soc Exp Biol. 1985;39:351-72 [PMID: 2871634]
  74. Lancet. 2016 Mar 19;387(10024):1178-86 [PMID: 26803443]
  75. ESC Heart Fail. 2020 Oct;7(5):2871-2883 [PMID: 32691522]
  76. Cardiovasc Drugs Ther. 1995 Aug;9(4):581-7 [PMID: 8547208]
  77. Am J Physiol. 1993 Nov;265(5 Pt 2):H1704-11 [PMID: 8238583]
  78. Circ Res. 1970 Jan;26(1):111-27 [PMID: 5410091]
  79. Biophys J. 2008 May 1;94(9):3577-89 [PMID: 18212018]
  80. Circ Res. 2018 Aug 17;123(5):601-613 [PMID: 30355138]
  81. Prog Biophys Mol Biol. 2021 Jan;159:118-125 [PMID: 32565182]
  82. Circulation. 1990 Oct;82(4):1266-78 [PMID: 2205417]
  83. JAMA Cardiol. 2021 Jul 1;6(7):762-768 [PMID: 33851966]
  84. J Mol Cell Cardiol. 2020 Feb;139:113-123 [PMID: 31982426]
  85. Circ Res. 2000 Mar 3;86(4):386-90 [PMID: 10700442]
  86. BMC Med. 2020 May 5;18(1):103 [PMID: 32366251]
  87. Circ Res. 1988 Dec;63(6):1080-9 [PMID: 3197273]
  88. Circ Res. 1996 May;78(5):893-902 [PMID: 8620610]
  89. J Clin Invest. 1988 Nov;82(5):1592-605 [PMID: 2460503]
  90. Am J Physiol Heart Circ Physiol. 2015 Feb 1;308(3):H240-9 [PMID: 25485900]
  91. Br J Pharmacol. 1989 Apr;96(4):927-39 [PMID: 2743084]
  92. Ann N Y Acad Sci. 1978 Apr 28;307:491-522 [PMID: 360947]
  93. Subcell Biochem. 2007;42:175-90 [PMID: 17612051]
  94. J Cell Mol Med. 2013 Jun;17(6):693-703 [PMID: 23402217]
  95. Eur Heart J. 2015 Sep 1;36(33):2257-66 [PMID: 26069213]
  96. Nature. 1979 Sep 13;281(5727):146-8 [PMID: 471060]
  97. J Bioenerg Biomembr. 2005 Dec;37(6):375-80 [PMID: 16691468]
  98. Circ Res. 2010 Oct 29;107(9):1150-61 [PMID: 20814023]
  99. J Mol Cell Cardiol. 1992 Dec;24(12):1459-70 [PMID: 1338113]
  100. Circ Res. 1990 Mar;66(3):696-709 [PMID: 2155067]
  101. J Card Fail. 2009 Apr;15(3):171-81 [PMID: 19327618]
  102. Am J Physiol. 1970 Jun;218(6):1682-6 [PMID: 5446298]
  103. Lancet. 1993 Dec 11;342(8885):1441-6 [PMID: 7902479]
  104. Am Heart J. 1971 Apr;81(4):572-3 [PMID: 5552057]
  105. Cardiovasc Drugs Ther. 1991 Dec;5(6):961-5 [PMID: 1801894]
  106. Environ Health Perspect. 1990 Mar;84:75-81 [PMID: 2190821]
  107. Am J Physiol. 1999 Aug;277(2):H474-80 [PMID: 10444471]
  108. J Clin Invest. 1990 May;85(5):1599-613 [PMID: 2332508]
  109. Circ Res. 1963 Jun;12:597-610 [PMID: 13988952]
  110. Methods Cell Biol. 1994;40:305-38 [PMID: 8201982]
  111. Eur J Heart Fail. 2014 Sep;16(9):1026-38 [PMID: 25056511]
  112. Hypertension. 2020 Jun;75(6):1334-1357 [PMID: 32370572]
  113. Methods Mol Biol. 2017;1521:3-14 [PMID: 27910038]
  114. Biochem Biophys Res Commun. 2003 Jan 10;300(2):592-9 [PMID: 12504124]
  115. World J Cardiol. 2015 Apr 26;7(4):204-14 [PMID: 25914789]
  116. Front Physiol. 2018 Dec 13;9:1785 [PMID: 30618800]
  117. Biomed Pharmacother. 2018 May;101:74-86 [PMID: 29477474]
  118. Neurosci Lett. 2020 Oct 15;737:135320 [PMID: 32841712]
  119. Front Mol Biosci. 2021 Jun 01;8:668129 [PMID: 34141722]
  120. Ann N Y Acad Sci. 2005 Jun;1047:86-98 [PMID: 16093487]
  121. JACC Basic Transl Sci. 2017 Oct 30;2(5):575-590 [PMID: 30062171]
  122. Am J Physiol Heart Circ Physiol. 2021 Mar 1;320(3):H1156-H1169 [PMID: 33449852]
  123. Br J Pharmacol. 1985 May;85(1):97-108 [PMID: 2992656]
  124. Nutrients. 2019 Sep 04;11(9): [PMID: 31487802]
  125. Sci STKE. 2005 May 03;2005(282):tr14 [PMID: 15870425]
  126. Antioxidants (Basel). 2020 Apr 22;9(4): [PMID: 32331285]
  127. Circ Arrhythm Electrophysiol. 2021 Feb;14(2):e009291 [PMID: 33417472]
  128. Am J Physiol Heart Circ Physiol. 2015 Feb 1;308(3):H157-82 [PMID: 25416190]
  129. Circ Arrhythm Electrophysiol. 2018 Apr;11(4):e005682 [PMID: 29654126]
  130. J Physiol Sci. 2020 Feb 5;70(1):4 [PMID: 32039693]
  131. J Mol Cell Cardiol. 2019 Feb;127:246-259 [PMID: 30633874]
  132. J Comp Pathol. 1991 Jan;104(1):33-45 [PMID: 2019674]
  133. J Comp Physiol B. 1991;161(1):19-25 [PMID: 2056155]
  134. Am J Cardiol. 1983 Sep 1;52(5):626-8 [PMID: 6684389]
  135. J Heart Lung Transplant. 1997 Nov;16(11):1157-67 [PMID: 9402516]
  136. JAMA. 2006 Jan 11;295(2):165-71 [PMID: 16403928]
  137. FASEB J. 2020 Sep;34(9):12114-12126 [PMID: 32681584]
  138. Sci STKE. 2005 Aug 02;2005(295):re8 [PMID: 16077087]
  139. Front Pharmacol. 2020 Feb 05;11:35 [PMID: 32116711]
  140. J Am Heart Assoc. 2017 Dec 21;6(12): [PMID: 29269353]
  141. JCI Insight. 2020 Dec 3;5(23): [PMID: 33119551]
  142. Expert Opin Drug Metab Toxicol. 2009 Jun;5(6):647-60 [PMID: 19442031]
  143. Lab Anim Sci. 1996 Aug;46(4):399-404 [PMID: 8872990]
  144. Circulation. 1987 Feb;75(2):331-9 [PMID: 2433073]
  145. Curr Opin Cardiol. 1994 May;9(3):369-78 [PMID: 8049595]
  146. Comp Biochem Physiol Physiol. 1994 Sep;109(1):1-22 [PMID: 8076447]
  147. Circulation. 1992 Dec;86(6):1819-26 [PMID: 1451254]
  148. Proc Natl Acad Sci U S A. 2017 Jun 6;114(23):E4582-E4591 [PMID: 28526717]
  149. Biomed Res Int. 2020 Apr 6;2020:6456805 [PMID: 32337263]
  150. J Clin Invest. 2006 Dec;116(12):3114-26 [PMID: 17099778]
  151. J Mol Cell Cardiol. 1991 Jan;23(1):65-75 [PMID: 1828088]
  152. Circ Res. 2018 Mar 16;122(6):821-835 [PMID: 29352041]
  153. Pflugers Arch. 1974 Mar 11;347(3):185-98 [PMID: 4857070]
  154. J Am Coll Cardiol. 2018 May 15;71(19):e127-e248 [PMID: 29146535]
  155. Sci STKE. 2005 Feb 22;2005(272):re3 [PMID: 15728426]
  156. Am J Physiol Heart Circ Physiol. 2015 Mar 15;308(6):H637-50 [PMID: 25576627]
  157. Circulation. 2000 Apr 11;101(14):1679-85 [PMID: 10758050]
  158. Eur Heart J. 2020 Jan 14;41(3):407-477 [PMID: 31504439]
  159. J Clin Invest. 1988 Nov;82(5):1578-84 [PMID: 3183055]
  160. Life Sci. 2020 Jun 15;251:117631 [PMID: 32251635]
  161. N Engl J Med. 2020 May 14;382(20):1883-1893 [PMID: 32222134]
  162. Ann N Y Acad Sci. 2020 Aug;1474(1):27-46 [PMID: 32901453]
  163. Eur Heart J. 2018 Sep 1;39(33):3021-3104 [PMID: 30165516]
  164. Pflugers Arch. 1989 Apr;413(6):637-43 [PMID: 2726426]
  165. Fed Proc. 1975 Apr;34(5):1379-81 [PMID: 1079007]
  166. Korean J Intern Med. 2021 Mar;36(Suppl 1):S62-S71 [PMID: 32615654]
  167. Heart Rhythm. 2020 Mar;17(3):503-511 [PMID: 31622781]
  168. Pharmacol Ther. 2017 Aug;176:22-31 [PMID: 27742568]
  169. Cells. 2020 Feb 26;9(3): [PMID: 32111102]
  170. Circulation. 2011 Jul 19;124(3):304-13 [PMID: 21709064]
  171. Nat Rev Cardiol. 2019 Jun;16(6):344-360 [PMID: 30664669]
  172. Am J Physiol. 1992 Nov;263(5 Pt 2):H1576-86 [PMID: 1443209]
  173. Circulation. 2017 Aug 8;136(6):e137-e161 [PMID: 28455343]
  174. Circulation. 1995 Sep 1;92(5):1169-78 [PMID: 7648662]
  175. Nat Rev Dis Primers. 2020 Mar 5;6(1):16 [PMID: 32139695]
  176. Cardiovasc Drugs Ther. 1999 Sep;13(5):455-63 [PMID: 10547227]
  177. Circ Res. 1990 Sep;67(3):744-52 [PMID: 2204499]
  178. Prog Biophys Mol Biol. 2021 Jan;159:105-117 [PMID: 33031824]
  179. J Card Fail. 1995 Sep;1(4):311-21 [PMID: 9420664]
  180. Circ Res. 1993 Dec;73(6):1077-89 [PMID: 8222079]
  181. Photochem Photobiol. 2017 Mar;93(2):448-465 [PMID: 27925224]
  182. Am J Transl Res. 2020 Dec 15;12(12):7625-7639 [PMID: 33437349]
  183. Circ Res. 2017 Jan 6;120(1):33-35 [PMID: 28057788]
  184. Oncotarget. 2018 Feb 8;9(18):14042-14057 [PMID: 29581825]
  185. Am Heart J. 1999 Jul;138(1 Pt 1):78-86 [PMID: 10385768]
  186. Circ Res. 2011 Jan 21;108(2):265-72 [PMID: 21252153]
  187. J Med Chem. 2017 Jun 22;60(12):5146-5161 [PMID: 28557445]
  188. JACC Heart Fail. 2014 Feb;2(1):84-92 [PMID: 24622121]
  189. J Physiol. 2017 Aug 15;595(16):5545-5555 [PMID: 28617952]
  190. J Pharmacol Exp Ther. 1994 Aug;270(2):831-9 [PMID: 8071875]
  191. Future Cardiol. 2021 Jun 1;: [PMID: 34060323]
  192. BMC Physiol. 2003 Jul 21;3:6 [PMID: 12873352]
  193. Cell Calcium. 1991 Oct;12(9):635-43 [PMID: 1959127]
  194. Expert Opin Investig Drugs. 2006 Jul;15(7):733-42 [PMID: 16787138]
  195. Mol Biol Rep. 2021 Feb;48(2):1217-1223 [PMID: 33523372]
  196. Lancet. 2004 Dec 4-10;364(9450):2021-9 [PMID: 15582059]
  197. Lancet. 2014 May 31;383(9932):1889-98 [PMID: 24881993]
  198. Circulation. 2018 Sep 25;138(13):e272-e391 [PMID: 29084731]
  199. J Mol Cell Cardiol. 1990 Jan;22(1):99-110 [PMID: 1691300]
  200. Front Pharmacol. 2014 Apr 02;5:59 [PMID: 24765077]
  201. Circ Res. 2020 May 8;126(10):e80-e96 [PMID: 32134364]
  202. Circulation. 1986 Mar;73(3 Pt 2):III65-77 [PMID: 3943182]
  203. J Hypertens. 2017 Mar;35(3):602-611 [PMID: 28009703]
  204. J Physiol. 1975 Aug;249(3):469-95 [PMID: 809571]
  205. Cardiovasc Res. 2011 Aug 1;91(3):465-71 [PMID: 21427121]
  206. Am J Physiol. 1999 May;276(5):H1678-90 [PMID: 10330254]
  207. Pharmacol Rev. 2016 Apr;68(2):476-532 [PMID: 27037223]
  208. Heart Rhythm. 2019 Oct;16(10):1575-1583 [PMID: 30954598]
  209. Nature. 2002 Jan 10;415(6868):198-205 [PMID: 11805843]
  210. Circulation. 2021 Feb 23;143(8):e254-e743 [PMID: 33501848]
  211. Circulation. 2016 Dec 6;134(23):e579-e646 [PMID: 27832612]
  212. Front Physiol. 2018 Aug 07;9:1081 [PMID: 30131723]
  213. Cell Calcium. 1990 Sep;11(8):531-8 [PMID: 2148283]
  214. Cardiovasc Res. 2015 Apr 1;106(1):163-73 [PMID: 25631581]
  215. Front Cardiovasc Med. 2020 Feb 25;7:24 [PMID: 32158769]
  216. Circ Res. 2017 Jul 7;121(2):181-195 [PMID: 28684623]
  217. FASEB J. 2018 Aug;32(8):4229-4240 [PMID: 29490168]
  218. J Mol Cell Cardiol. 1989 Oct;21(10):1037-45 [PMID: 2555525]
  219. Cardiovasc Res. 1995 Apr;29(4):475-81 [PMID: 7796440]
  220. J Am Coll Cardiol. 2020 Dec 22;76(25):2982-3021 [PMID: 33309175]
  221. Curr Opin Cardiol. 1994 May;9(3):357-68 [PMID: 8049594]
  222. Cardiovasc Ther. 2020 Dec 16;2020:6615038 [PMID: 33381229]
  223. Eur Heart J. 2016 Jun 1;37(21):1651-8 [PMID: 26922809]
  224. Am J Physiol. 1968 Apr;214(4):730-6 [PMID: 5642933]
  225. Intern Med. 2018 Feb 1;57(3):311-318 [PMID: 29093384]
  226. Cardiovasc Res. 1993 Dec;27(12):2212-21 [PMID: 8313431]
  227. Circ Res. 2014 Aug 29;115(6):567-580 [PMID: 25047165]
  228. Yale J Biol Med. 1994 Sep-Dec;67(5-6):247-64 [PMID: 8579641]

Grants

  1. R01HL49574; R01HL49574; R01HL39091; R01HL97979; R01HL133294/NIH HHS
  2. R01 HL157116/NHLBI NIH HHS
  3. R01 HL133294/NHLBI NIH HHS
  4. PMAYP/Prince Mahidol Award Foundation, Thailand
  5. 19TPA34900003/American Heart Association

MeSH Term

Adenosine Triphosphatases
Adrenergic beta-1 Receptor Agonists
Adrenergic beta-Antagonists
Animals
Antioxidants
Ca(2+) Mg(2+)-ATPase
Calcium
Calcium-Calmodulin-Dependent Protein Kinase Type 2
Cardiotonic Agents
Dobutamine
Heart Failure
Humans
Myocardial Contraction
Sarcoplasmic Reticulum

Chemicals

Adrenergic beta-1 Receptor Agonists
Adrenergic beta-Antagonists
Antioxidants
Cardiotonic Agents
Dobutamine
Calcium-Calmodulin-Dependent Protein Kinase Type 2
Adenosine Triphosphatases
Ca(2+) Mg(2+)-ATPase
Calcium

Word Cloud

Created with Highcharts 10.0.0heartfailuretherapeuticprevalenceevenapproachessarcoplasmicreticulumoccurrenceremainhighUnitedStateswellgloballyOnepersondiesevery30sdiseaseRecognizingimportancecliniciansscientistssoughtbetterstrategiescuresend-stageexplorationresultedmanyfailedclinicaltrialstestingnovelclassespharmaceuticaldrugsgenetherapyresultalongwayparadigmshiftstowardawaydifferingcontinueddeathhoweverclearlydemonstratessimplypumpinsteadforcesusconsidercomplexitysimplicitypathophysiologyreinforcesneeddiscovernewCalciumHeartFailure:GetGoing?betablockercalciumtransientexcitation–contractioncouplinghypoxiainotropemyocardialcontractilitymyofilamentCa2+ATPase

Similar Articles

Cited By